Cancer Biology & Medicine為季刊，國內(nèi)外公開發(fā)行，由中國科學(xué)技術(shù)協(xié)會(huì)主管、中國抗癌協(xié)會(huì)主辦，主編為我國著名腫瘤學(xué)專家郝希山院士。作為中國抗癌協(xié)會(huì)國內(nèi)外學(xué)術(shù)交流的重要媒介，以腫瘤臨床醫(yī)師、基礎(chǔ)研究人員、相關(guān)交叉學(xué)科專業(yè)人員及醫(yī)學(xué)生為讀者對(duì)象，向國際學(xué)術(shù)界展示中國腫瘤防治研究成果，向國內(nèi)腫瘤學(xué)相關(guān)專業(yè)人員介紹全球腫瘤學(xué)前沿進(jìn)展?？歉寮懂牐耗[瘤表觀遺傳學(xué)、腫瘤干細(xì)胞生物學(xué)、分子與臨床免疫學(xué)、腫瘤預(yù)防與流行病學(xué)、腫瘤標(biāo)志物、腫瘤影像學(xué)、腫瘤臨床試驗(yàn)、腫瘤靶向治療、腫瘤生物治療、腫瘤個(gè)體化醫(yī)學(xué)與多學(xué)科綜合治療。設(shè)有述評(píng)、綜述、論著、臨床指南、會(huì)議報(bào)道、病例報(bào)告、讀者來信等欄目。

Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:

● Cancer genetics

● Cancer and stem cell biology

● Molecular and clinical immunology

● Cancer prevention and epidemiology

● Cancer biomarkers

● Radiation oncology

● Oncology clinical trials

● Mechanisms of drug sensitivity and resistance

● Targeted therapy and immunotherapy

● Multidisciplinary treatment and personalized medicine